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Abstract
Background: Genomic copy number changes and regional alterations in epigenetic states have been linked to
grade in breast cancer. However, the relative contribution of specific alterations to the pathology of different breast
cancer subtypes remains unclear. The heterogeneity and interplay of genomic and epigenetic variations means
that large datasets and statistical data mining methods are required to uncover recurrent patterns that are likely to
be important in cancer progression.
Results: We employed ridge regression to model the relationship between regional changes in gene expression
and proliferation. Regional features were extracted from tumour gene expression data using a novel clustering
method, called genomic distance entrained agglomerative (GDEC) clustering. Using gene expression data in this
way provides a simple means of integrating the phenotypic effects of both copy number aberrations and
alterations in chromatin state. We show that regional metagenes derived from GDEC clustering are representative
of recurrent regions of epigenetic regulation or copy number aberrations in breast cancer. Furthermore, detected
patterns of genomic alterations are conserved across independent oestrogen receptor positive breast cancer
datasets. Sequential competitive metagene selection was used to reveal the relative importance of genomic
regions in predicting proliferation rate. The predictive model suggested additive interactions between the most
informative regions such as 8p22-12 and 8q13-22.
Conclusions: Data-mining of large-scale microarray gene expression datasets can reveal regional clusters of co-
ordinate gene expression, independent of cause. By correlating these clusters with tumour proliferation we have
identified a number of genomic regions that act together to promote proliferation in ER+ breast cancer.
Identification of such regions should enable prioritisation of genomic regions for combinatorial functional studies
to pinpoint the key genes and interactions contributing to tumourigenicity.
Background
The field of breast cancer research was amongst the first
to adopt genomic profiling tools such as competitive
genomic hybridisation (aCGH) and DNA methylation
analysis in order to investigate the molecular basis of
disease progression. Studies using aCGH to examine
DNA copy number changes in breast tumours have
demonstrated that the copy number aberrations (CNAs)
are not random, but are more prevalent in particular
chromosomal locations [1-4]. Indeed, it has become
evident that patterns of genomic rearrangements differ
between disease subtypes, and may be of prognostic
significance [1-4]. It is clear from these studies that par-
ticular genomic copy number aberrations are associated
with tumour grade. Furthermore, local DNA copy num-
ber changes have been shown to cause gene expression
changes such that a majority of the genes in gained or
amplified regions exhibit increased expression [5].
Similarly, regional epigenetic changes involving DNA
methylation and chromatin structure which lead to or
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involved in breast cancer [6]. The interplay of alterations
in DNA copy number and epigenetic states is complex,
and to understand the full picture data from multiple
sources needs to be integrated. Since both copy number
and epigenetic alterations result in changes in gene
expression patterns, analysis of microarray gene expres-
sion data in the context of specific genomic regions is
an efficient means of integrating the effects of genomic
changes in cancer.
Oestrogen receptor positive (ER+) breast cancer repre-
sents the most prevalent breast cancer subtype, and
although several anti-oestrogen therapies are available to
treat hormone dependent disease, resistance to therapy
is common and the full molecular basis of the disease is
not fully understood. In this study we have assembled
data from ER+ tumours within five published large-scale
microarray gene expression datasets and developed a
computational analysis approach to score the contribu-
tions of genomic regions with altered gene expression to
proliferation and hence grade.
Previous analysis of gene expression profiles from ER+
breast tumours has implicated a set of highly correlated
genes involved in cell proliferation as a key prognostic
feature [7]. This proliferation signature is highly
enriched with genes known to be cell-cycle regulated
and therefore provides an array-based mitotic index
[7-9]. When correlates of histological grade were sought
in gene expression profiles, most of the genes selected
were those previously found in the proliferation signa-
ture [10,11]. Moreover, it has been demonstrated that
the array-based “Genomic Grade Index” was, at least for
ER+ breast cancer, more accurate than histological
grade in predicting clinical outcome [12]. We explore
the relationship of the proliferation signature to geno-
mic regions that display marked covariant gene expres-
sion across a large number of tumours.
Patterns of gene expression that are associated with
particular aspects of sample phenotype are often
referred to as “signatures”. This term has been used
quite broadly both for clusters of co-regulated and thus
correlated genes such as in the proliferation signature
[7-9], but also for more complex expression profiles that
involve a number of loosely, or even inversely, corre-
lated gene clusters. Like others [13,14] we have adopted
the more operationally defined and analytically useful
metagene approach, in which clusters of correlated
genes are replaced by statistical summaries of them;
here we use cluster centroids (mean vectors). The meta-
gene approach sacrifices detail at the individual gene
level in order to gain statistical robustness, generalisabil-
ity and the necessary dimension reduction to enable
higher-level analysis.
The analysis of gene expression data from ER+ breast
cancer that we present here involves a number of stages.
Firstly, we describe a novel clustering algorithm (GDEC)
that uses genomic distance together with expression
data to reveal regional patterns of co-ordinate gene
expression. We show that many, but importantly not all,
of these regional clusters reflect common CNAs in this
type of cancer. We derive metagenes as cluster centroids
and we refer to metagenes derived from GDEC clusters
as regional metagenes (RMGs). We use regression analy-
sis with the RMGs to identify the most important
regions for the prediction of proliferation as defined by
the proliferation metagene.
Results and Discussion
Genomic distance entrained clustering
We have developed a novel clustering method, called
Genomic Distance (GDEC) Entrained Clustering, to
identify genomic regions where gene expression is co-
ordinately altered. The algorithm reduces the correlation
distance between genes in the same chromosomal
neighbourhood in a genomic distance and correlation
dependent manner. This type of data clustering is gener-
ically known as clustering with side-information or clus-
tering with soft constraints and is more typically used in
geographical applications [15]. Details of the algorithm
and the parameters used are provided in the methods
section.
To establish the effect of GDEC clustering we com-
pared the chromosomal composition of clusters derived
from GDEC and standard flexible beta clustering, using
ER+ samples from three published breast cancer gene
expression datasets [11,16-19]. The results indicate a
clear enrichment in clusters with a high proportion of
genes from the same chromosome in the GDEC clus-
tered data (green versus red lines in Figure 1). These
results were also compared to those obtained when the
correlation structure in the datasets was destroyed by
permuting the values in each row (gene) in the data
matrix. The enrichment profiles for the permuted data
are only slightly higher than that expected when chro-
mosomes are randomly assigned to clusters (Figure 1).
At the parameter settings used in this study, the influ-
ence of genomic distance does not dominate the gene-
expression data, but rather reveals genomic regions of
correlated gene expression. Thus, GDEC clustering gives
a significant enrichment in genes from the same geno-
mic locus in individual clusters, compared to traditional
clustering techniques.
Identification of recurrent regional metagenes
A tree-cutting method was used to segregate clusters
from the dendrogram generated by GDEC clustering.
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Page 2 of 14Figure 1 Enrichment of clusters with genes from the same chromosome. The dendrograms resulting from standard flexible beta and GDEC
clustering were cut at 200 clusters. The chromosomal locations of the genes in each cluster were tabulated, and for each cluster the number of
genes from the most abundantly represented chromosome was scored as a fraction of the number of genes in the cluster. These proportion
scores are plotted in ranked order from left to right for each of the three largest datasets. The red lines indicate GDEC clustering, the green lines
standard flexible beta clustering and the blue lines GDEC clustering after destruction of correlation structure by permutation. The single black
line indicates the profile obtained by randomly assigning genes to clusters.
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Page 3 of 14Regional metagenes (RMGs) were then defined as the
centroids of clusters containing >90% genes from the
same chromosome, giving rise to between 31 and 45
clusters per dataset. Comparison of the metagenes
across studies revealed a number of regions conserved
in at least four out of five datasets (Additional File 1),
suggesting that this analysis has identified recurrent bio-
logical features. Permutation analysis yielded a maxi-
mum intersection gene list size of 10 genes only 3 times
in 100,000 trials inferring a p-value close to zero for the
234 genes found in common to the regional metagenes
listed in Additional File 1. Among the recurrently identi-
fied regions, differences were found in the extent of
these clusters, as illustrated in Figure 2, which indicates
the overlaps in the regional clusters on chromosome 8
for the five datasets. A marked sample set dependency
was observed for many regions represented in less than
four out of the five datasets.
Regional metagenes, copy number aberrations and
proliferation
The prognostic significance of the proliferative pheno-
type in these tumours as assessed by the proliferation
signature has been emphasized by others [7,10]. In
order to determine the relationship between RMGs and
proliferation, we derived a proliferation metagene. For
this we identified the cluster containing most of the
genes reported in published proliferation signatures
[7-9] in each of the three larger datasets then defined
the proliferation metagene as the intersection of these
three clusters (see methods for further details). Histo-
g r a m so fc o r r e l a t i o n so ft h em o s tv a r i a b l eg e n e st ot h e
proliferation metagene are given in Additional File 2,
and the genes that comprise the proliferation signature
are detailed in Additional File 3. In each dataset the
genes that constitute the proliferation cluster form a
small shoulder in the distribution with correlations
greater than 0.5. In order to use the proliferation meta-
gene as a continuous marker of proliferation, we
excluded all genes with a high correlation to the prolif-
eration metagene (correlation >0.5) from the analysis
prior to clustering. We demonstrate in a subsequent
section that the proliferation metagene is a reliable sur-
rogate of tumour grade [10,12] and results in a good
separation of grade 1 and 3 tumours (Figure 4).
To examine the possible correspondence between
regional metagenes, DNA copy number changes and
proliferation we used a study detailing parallel gene
expression and CGH copy number analysis for 43 ER+
breast tumours [20]. We constructed a frequency plot
for copy number aberrations (CNAs) from the CGH
data and plotted this in parallel with the correlation of
the RMGs to the proliferation metagene from the paired
gene expression data in this study (Figure 3). Recurrent
RMGs on chromosomes 3, 8, 11, 17 and 20 exhibit a
pattern in which most copy number gains and losses
correspond to positive and negative correlation to the
proliferation metagene respectively. However, not all
differentially expressed regions showed corresponding
differences in DNA copy number (e.g. 7p15) suggesting
that alternative mechanisms of gene expression regula-
tion, such as epigenetic repression, are important in
defining regional metagenes. DNA copy number loss
and epigenetic silencing may also be alternative or addi-
tive mechanisms at regions such as 3p21 [21]. This
demonstrates the integrative power of our approach,
and its potential to define areas where copy number
changes have real phenotypic consequences.
Identification of regional metagenes predictive of
proliferation
To investigate if regional clusters of co-expressed genes
are predictive of proliferation, ridge regression was used
to calculate weightings for regional metagenes when the
proliferation metagene was used as the response variable
(see methods). To validate the method we tested the
regression models derived from individual datasets by
using the other four datasets as validation datasets.
In each case, RMGs were extracted from the validation
datasets exactly as for the training dataset and the pre-
dicted proliferation metagene was calculated using the
weightings derived from the training dataset. In most
cases the correlations for the training sets were higher
than the test predictions, indicating some degree of
overfitting (Table 1). However, the test-set correlations
were all significant, suggesting that the predictive signifi-
cance of the RMGs and their calculated regression
weightings were transferable between datasets. Thus,
despite sample set differences in the RMGs, there was a
repeated pattern of relationships between the prolifera-
tion metagene and the regional clusters of co-expressed
genes.
Regional metagenes contribute additively to proliferation
To simplify the analysis and increase the sample size,
five datasets were merged (see methods). We used
GDEC clustering and the tree cutting method to derive
42 RMGs, and performed regression analysis as above
(Additional File 4). The training fit gave a correlation of
0.82 to the proliferation metagene. To estimate the
extent of overfitting we randomly split the dataset into
two halves, and used both as a training set to derive
weightings to predict the proliferation metagene of the
other. This was repeated 500 times giving an average
correlation of 0.79. Thus, by using a larger dataset we
have reduced overfitting (see Figure 4).
Ak e yq u e s t i o nf o rt h i sa n a l y s i si sw h e t h e rt h e
multivariate regression models used here
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Page 4 of 14Figure 2 Common regions of co-expression on chromosome 8. The extent of the regional clusters for chromosome 8 are shown as
coloured bars for each of the five datasets used. The regions of overlap between the studies are delineated by horizontal lines with the
cytoband ranges labelled on the right. Although not indicated, the Tbig dataset has two overlapping regional metagenes on the q-arm.
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Page 5 of 14significantly improve on the correlation of the best
individual RMG in the set of 42. The RMG with
the highest absolute correlation to the proliferation
signature was that at chromosome 8q13-8q22, with
a correlation of 0.52 (Table 2). The lowest of the
permutation test correlations was 0.75 (Figure 4b),
and this conservative estimate of the accuracy of
the model was still significantly higher than the
most informative RMG (Fisher’sz - s c o r em e t h o d ,p -
value 1.35
E-8). We conclude that the RMGs provide
information additively in predicting proliferation. As
the most informative RMGs reflect common CNA’s
or regions of epigenetic silencing, we suggest that
these genomic modifications act co-operatively and
additively to produce cancers with higher prolifera-
tive capacity.
Competitive selection of regional metagenes
To investigate the relative importance of RMGs in pre-
dicting proliferation we used a forward selection method
in combination with sample subset permutations. A
hundred random samples, each of 396 tumours, were
drawn from the merged dataset of 793 profiles. For each
sample, the RMG with the highest absolute correlation
to the proliferation metagene was chosen as the seed
RMG. The RMG that best improved the regression fit
was then selected from those remaining and added to
the model, until all 42 RMGs were included. The selec-
tion order was recorded for each of the 100 permuta-
tions and the ranks were averaged to give the final
selection order (Table 2). The cumulative correlation of
the fit to the proliferation metagene at each step is
depicted in Figure 5.
Figure 3 Comparison of regional metagenes and DNA copy number changes. A) Frequency plot of DNA copy number changes from 43 ER+
breast tumour CGH profiles [20]. B) Corresponding map of regional metagenes from matching gene expression data. C) Regional metagenes from
the merged dataset of 793 tumours. In B) and C) the height and direction of the plotted peaks indicate the correlation of the RMGs to the
proliferation metagene from the corresponding datasets.
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the first few metagenes added to the model, we ran the
selection order permutations four further times with
each of the first four RMGs omitted of the RMG set, in
order to observe the rank order changes that resulted.
The arrows in Figure 5 indicate the metagenes that
most frequently substituted for the omitted RMG. The
substituting RMGs that replaced the deleted RMGs
were not surprisingly correlated with them, illustrating
some redundancy amongst the RMGs. In the first case
the RMG at 8q24 is frequently gained along with the
region at 8q13-22 and is highly correlated to
proliferation, but was pushed down the selection order
presumably because it provided redundant information
once the 8q13-22 RMG had been selected. This effect
caused the selection order to deviate from a decreasing
order of absolute correlations. For example, the third
RMG selected, 11q13 has a lower correlation to the pro-
liferation signature (0.38) than the RMG at 8q24 (0.47).
In selection order analyses for the individual datasets we
consistently found that the top two RMGs contained an
RMG at 8p22 together with one of three RMGs from 8q
(data not shown). The RMGs on 8q probably carry
redundant information and possibility reflect the com-
mon gains of the q-arm of chromosome 8 in breast can-
cer [20]. Consequently, the 11q13 RMG was more
consistently able to provide additional, non redundant
information to the model than a second RMG from 8q.
Thus, our method establishes not only the regions that
contribute most to proliferation, but also highlights the
relationships between them such that the more orthogo-
nal, and consequently the most additive combinations
are selected with higher priority.
Model Validation
T h et o pt h r e eR M G st h a tw e r es e l e c t e du s i n go u r
method reflect known genomic copy number aberrations
Table 1 Correlation of the RMG regression fit across
datasets
Oxford Stockholm Tbig Uppsala Wang
Oxford 0.80 0.60 0.69 0.62 0.65
Stockholm 0.80 0.84 0.79 0.78 0.65
Tbig 0.73 0.68 0.82 0.66 0.62
Uppsala 0.76 0.74 0.75 0.82 0.76
Wang 0.67 0.63 0.66 0.69 0.78
The rows of this table represent the test datasets used and the columns
represent the training datasets used to derive the RMGs and determine their
regression weightings. The leading diagonal represents the correlations of the
training models.
Figure 4 Prediction of proliferation signal in combined dataset. A) A scatter plot of showing the correlation to the proliferation metagene
for the combined dataset containing 793 ER+ breast cancer samples, with the histological grade colour coded where blue is grade 1, red is
grade 3 and grey indicates either grade 2 or missing value. The correlation of this fit is indicated in the upper left corner. B) A histogram of
correlations for the predictions for 500 permutations in which the combined dataset was randomly split into two and each half was used to
predict the proliferation metagene of the other half. The lambda value was fixed at an optimal value of 120 based on a prior set of cross-
validations.
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Page 7 of 14in breast cancer, thus validating this method. Further-
more, the positively correlated RMGs 8q13-22 and 11q13
are in regions known to be gained, and the negatively
correlated 8p22 RMG in a region of common loss [20].
Indeed, comparisons of DNA copy number changes
between luminal A and luminal B type breast cancers,
corresponding to low and high grade respectively, indi-
cated that the frequency of gain on 8q and loss on 8p
was much greater in the more proliferative luminal B
subtype [20].
This analysis approach also highlighted the impor-
tance of the HOXA cluster at 7p15 (RMG4), which has
been shown to undergo epigenetic silencing in tumours
[22]. The HOXA genes have been implicated in growth
suppression and apoptosis via a p53-dependent pathway
[23,24]. The consistent selection of the HOXA cluster
on chromosome 7p15 in the sequential model building
method, suggests that down-regulation of these genes is
an additive event and not simply a consequence of rear-
rangements on chromosome 8.
The metagene at 3p21-14 (RMG5) contains the gene
IL17BR. This gene forms half of a two gene predictor
for response to tamoxifen treatment, along with
HOXB13. IL17BR has been shown to be significantly
negatively correlated to grade at the expression level in
a large panel of tumours [25], and is in a region where
loss has been associated with high grade [1].
Chromosome 1 frequently exhibits gain of the q arm
and loss of the p arm in breast cancer [20], with loss of
the p arm more frequent in luminal B type tumours.
We identified a region from 1q24-44 (RMG9) that was
positively correlated to proliferation, and a region at
1 p 1 3( R M G 1 3 )t h a tw a sn e g a t i v e l yc o r r e l a t e dt op r o l i f -
eration. Thus, this analysis can help pinpoint the loca-
tion of genes that drive cancer progression when
amplified or lost.
The metagene at 17p13 (RMG7) sits in a region that
undergoes copy number loss more frequently in luminal
B compared to luminal A tumours [20]. This RMG
spans the p53 gene and was negatively correlated to
proliferation. Epigenetic silencing at 7p15 and copy
number loss at 17p13 can both affect progression of
tumours with wild type p53, but are likely to be less
important in tumours that harbour p53 null mutations.
Detailed analysis of regional metagene interactions
An advantage of our method is that it can provide infor-
mation about genes not originally included in the analysis
by indicating the relative importance of a region. The
fifth most informative RMG at 3p21 spans the RASSF1
tumour suppressor gene. Although this gene was not
included in this study, the expression data for this gene
was found to be negatively correlated with the prolifera-
tion metagene and positively correlated with the meta-
gene at 3p21 (data not shown). This tumour suppressor
gene is frequently subject to epigenetic silencing via a
mechanism involving the regional spreading of hetero-
chromatin following failure of CTCF dependent insulator
sites [21]. In addition, RASSF1 negatively regulates the
Table 2 Selection order for regional metagenes in
prediction of proliferation
RMG Chr Cytobands Position (Mb) Genes Correlation
1 8 8q13.1 - 8q22.3 66.72 - 104.15 21 0.52
2 8 8p22 - 8p12 17.55 - 31.15 19 -0.41
3 11 11q13.1 - 11q13.4 66.01 - 70.89 11 0.38
4 7 7p15.2 - 7p15.2 27.15 - 27.18 4 -0.39
5 3 3p21.31 - 3p14.3 49.13 - 58.5 9 -0.26
6 16 16p13.3 - 16p13.2 0.04 - 8.86 12 0.45
7 17 17p13.3 - 17p11.2 0.59 - 19.71 19 -0.11
8 22 22q11.22 - 22q11.22 20.88 - 21.57 5 -0.04
9 1 1q24.2 - 1q44 166.15 - 245 23 0.13
10 23 23q28 - 23q28 148.67 - 153.54 8 0.32
11 19 19q13.11 - 19q13.43 40.22 - 63.77 34 -0.13
12 3 3q13.32 - 3q22.1 120.41 - 132.22 8 0.30
13 1 1p13.3 - 1p13.3 110 - 110.09 4 -0.29
14 16 16p13.3 - 16p13.2 0.71 - 8.78 8 -0.07
15 16 16q13 - 16q22.3 55.32 - 73.24 16 0.40
16 22 22q12.2 - 22q13.33 28.46 - 49.31 20 0.22
17 23 23q22.1 - 23q22.2 99.77 - 102.52 6 -0.31
18 6 6q14.2 - 6q23.3 83.93 - 137.41 9 0.14
19 7 7q21.12 - 7q22.3 86.81 - 107.05 9 -0.16
20 20 20p11.21 - 20q13.33 25.18 - 62.13 18 0.09
21 7 7q34 - 7q34 142.14 - 142.18 4 0.11
22 17 17p11.2 - 17q21.32 19.38 - 43.11 15 0.10
23 11 11q14.1 - 11q25 85.05 - 133.6 13 -0.20
24 11 11q12.2 - 11q13.4 60.86 - 72.62 11 0.20
25 5 5q13.1 - 5q13.2 69.21 - 70.46 8 -0.11
26 8 8q24.3 - 8q24.3 141.6 - 146.25 19 0.47
27 11 11q22.3 - 11q24.3 109.61 - 129.59 11 -0.02
28 17 17q23.3 - 17q25.3 58.86 - 78.25 24 0.27
29 18 18q11.2 - 18q21.33 17.48 - 59.14 14 -0.11
30 17 17q21.31 - 17q24.1 38.06 - 59.92 17 0.16
31 22 22q12.3 - 22q13.1 34.37 - 37.81 10 0.08
32 12 12p13.31 - 12p13.2 6.42 - 10.48 10 0.06
33 17 17q11.2 - 17q21.31 23.39 - 39.99 19 0.08
34 17 17q22 - 17q24.2 53.3 - 64.04 9 0.16
35 17 17q12 - 17q21.1 33.04 - 35.61 8 0.27
36 19 19q13.42 - 19q13.42 59.41 - 59.84 4 0.21
37 6 6q25.1 - 6q25.1 151.77 - 152.46 4 -0.01
38 8 8p12 - 8p11.21 37.74 - 42.87 8 0.14
39 19 19p13.3 - 19p13.13 0.94 - 12.93 10 0.27
40 19 19q13.2 - 19q13.2 46.07 - 46.29 4 -0.06
41 14 14q32.33 - 14q32.33 105.4 - 106.35 4 -0.07
42 6 6p22.1 - 6p21.32 26.47 - 32.94 12 0.11
The RMGs are numbered in selection order. The chromosome, cytobands,
position, number of genes and the correlation to the proliferation metagene
for the merged 793- sample dataset are shown.
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Page 8 of 14accumulation of cyclin D1 at a post-transcriptional level
[26], suggesting a potential example of an additive inter-
action, between cyclin D1 containing RMG at 11q13 and
the region at 3p21 (Figure 6). Bioinformatic data mining
of interactions and annotations of genes within interact-
ing genomic regions can be used to generate hypothesis
for functional studies to identify the key genetic interac-
tion within differentially expressed regions.
Interaction network analysis of regional metagenes
We have observed that most of the variation of the prolif-
eration metagene can be explained by the first seven
regional metagenes, and that these metagenes can be
replaced by others initially much further down the selec-
tion order. We hypothesised that RMGs at the top of the
selection order should carry non-redundant information,
and thus be involved in distinct pathways related to
common cell-biological processes. This led us to investi-
gate the networks of characterised protein interactions
between these top seven RMGs and the proliferation
metagene (Figure 7A and Additional File 5).
In most cases connections between RMGs were largely
mediated through a centralised component (shown in
black) comprising 2808 genes (36 belonging to RMGs 8
to 42) and 3050 interactions, the majority of which ema-
nated from a small number of non-metagene hubs
(BRAF, RAF1, DDB1, IMMT, DLG4, TRAF6 and
HCLS1). Most of these hubs interacted directly with
genes in the proliferation cluster. In the case of RMG 7
a significant number of direct interactions with the pro-
liferation metagene were observed, with TP53 and
PAFAH1B1 interacting with 17 proliferation metagenes
components including CDC2, CCNA2, RAD51 and
AURKA (Additional File 5).
Figure 5 The effect of RMG omission on selection order. This graph plots the cumulative correlation to the proliferation metagene for the
42 RMGs used in the competitive selection analysis. The slope of the curve indicates that most of the correlation is explained by the top 13
RMGs. Omission of each of the top four RMGs in turn resulted in their replacement in the selection order with previously lowly selected
metagenes (indicated by arrows).
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and those that replaced them when they were omitted, a
protein interaction network was generated from the pro-
liferation metagene and RMGs 1 to 4, 15, 17 and 26
(8q13-22, 8p12-22, 11q13, 7p15, 16q13-22, 23q22 and
8q24 respectively) and the direct or shortest indirect sig-
nalling interactions with the proliferation metagene
members were compared. For the top 3 RMGs (8q13-
22, 8p12-22 and 11q13), the replacing metagene hit a
subset of the respective proliferation metagene mem-
bers, indicating some functional equivalence (Figure 7B
and Additional File 6). Interestingly, this overlap was
n o to b s e r v e df o rR M G4( 7 p 1 5 )s u g g e s t i n gt h a t ,f o rt h e
HOX cluster, signalling to the proliferation metagene
may be mediated through additional interactions within
the centralised component (Figure 7A shown in black).
This analysis reiterates the finding that a number of
small changes in a set of complementary pathways driv-
ing cell growth and division can act additively to increase
cell proliferation. Furthermore, analysis of the RMGs that
carry redundant information can help to narrow down
the list of potential cancer drivers within RMGs.
Conclusions
We have shown that a small regional distortion of cor-
relation distance in agglomerative clustering results in
the formation of regional clusters of co-regulated genes.
We have constructed metagenes from these clusters and
used linear regression in the modelling of grade using
proliferation as a surrogate. Using this approach we
have identified 42 genomic regions where gene expres-
sion is recurrently altered in ER+ breast cancers. We
have gone on to identify the regions most correlated
with the proliferation signature. We show that distinct
genomic regions combine additively to enhance prolif-
eration, and that regions can be ranked by their contri-
bution to the proliferation rate in a competitive model.
As a result we have identified the differentially regulated
genomic regions that are most important in prolifera-
tion, and hence grade and prognosis, of ER+ breast can-
cer. Furthermore, detailed analysis of the interacting
regions has identified a number of possible genetic dri-
vers of cancer that are involved in key cellular pathways.
This approach will have utility in identifying and inte-
grating chromosomal regions where coordinate changes
Figure 6 Additivity of two RMGs in predicting proliferation. This surface plot depicts additivity between the third (11q13) and fifth (3p21-14)
RMGs in the prediction of the proliferation metagene. The plot was generated using locally weighted robust regression (Loess) at a span of 0.75.
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Page 10 of 14Figure 7 Interaction network associations of regional metagenes. A) Overview of the interaction network defined by the proliferation
metagenes and RMGs 1 to 7 (8q13-22, 8p12-22, 11q13, 7p15, 3p14-21, 16p13, 17p11-13 respectively). Light gray edges, protein-protein
interactions, red lines, transcriptional interactions, blue lines, interactions within protein complexes. Genes from RMGs 8 to 42 participating in
signalling within the network core are shown in magenta. Direct interactions between the proliferation metagenes and top seven RMGs gene
members are emphasized in bold. B) Close association in proliferation metagenes gene targets between RMG 2 (8p12-22) and RMG 17 (23q22).
Proliferation metagenes genes targeted only by RMG 2 are shown in green, those targeted only by RMG 17 are shown in salmon pink and those
targeted by both RMGs are highlighted in yellow.
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phenotypes.
Methods
Microarray data normalisation
Microarray gene expression data for five of the breast
cancer datasets used in this study, were obtained from
the GEO database (GSE6532, GSE1456, GSE3494,
GSE7390, GSE2034) [27]. The paired gene expression
and array comparative genomic hybridization data for
43 ER+ tumours [20] was downloaded from the data-
base referenced therein. The gene expression data from
all these studies was derived using the Affymetrix 133A
platform, comprised of the 22215 non-control probesets.
ER+ tumour samples were selected on the basis of histo-
logical sample annotation. MAS5 processed gene expres-
sion values were log2 transformed, and then quantile
normalization was applied across all samples [28]. Fol-
lowing transformation and normalisation probesets that
had a maximum expression level below 7, an inter-quar-
tile range below 0.5, or missing genomic mapping infor-
mation were excluded from the analysis. The gene
expression values for each gene were then standardised
to a mean of 0 and standard deviation of 1 within each
dataset. In the case of the combined dataset, this
resulted in a final matrix of 5466 probesets for 793
tumours.
T h en o r m a l i z e da C G Hd a t af r o m[ 2 0 ]w a ss m o o t h e d
using the DNAcopy R package from Bioconductor [29].
Gains and losses were defined as those log2 ratio values
that exceeded 0.2 and were less than -0.2 respectively.
Genomic distance entrained clustering algorithm
The GDEC clustering method used a modification of the
gene-gene correlation distance matrix prior to clustering
by the flexible beta agglomerative clustering algorithm
( 1
2
− ,- 1< b <1 )w i t hb = -0.5, because for small nega-
tive values of this parameter the space dilation during
clustering avoids chaining in the dense gene space [30].
For genes on the same chromosome a sigmoid function
was used to control the influence of genomic distance;
g
ax ij h
ij =−
+−−
1
1
1 exp( ( ))
,
where xij is the absolute genomic distance between
genes i and j in megabases, h is a parameter setting the
distance of half maximum influence, and a is parameter
controlling the steepness of change in influence with
distance. The genomic distance adjusted correlation dis-
tance, dij between genes i and j, is then calculated by
the following function;
dg
ij
g ij ij ij ij =
+
+− − 


2
12
11
exp( )
() ( )
where rij is the Pearson correlation, and l is a scaling
parameter that controls the extend of distance distor-
tion. In this study the parameters where fixed at; a =
0.25, l =0 . 5 ,h = 10 Mb. A three-dimensional plot of
the function is provided in additional file 7.
Metagene construction
The proliferation metagene was derived as follows. The
most variable genes from the three larger datasets used
here (Tbig, Uppsala and Wang) were clustered by stan-
dard flexible beta clustering and the dendrograms cut to
give 100 clusters. In each of the three sets of 100 clus-
ters, a single cluster was identified that contained most
of the genes found in published proliferation signatures
[7-9]. The gene list used to derive the proliferation
metagene used here was taken as the intersection of
these three clusters. When the proliferation metagenes
were derived de novo for each of the individual datasets,
by identifying the proliferation cluster as above, the cor-
relation of this de novo proliferation metagene to the
proliferation metagene from the intersection gene list
was always high (worst case 0.956). This supports the
use of metagenes as stable and transferable estimates of
recurrent expression patterns.
All metagenes were derived as the mean vector of the
genes in the corresponding cluster following standardi-
zation to mean of 0 and standard deviation of 1. In
order to avoid biased gene weighting, values from dupli-
cate probesets for the same gene (UniGene Cluster)
were averaged prior to averaging across different genes
in metagene calculation. For clusters that derived less
than 100% of their genes from the same chromosomal
region (i.e. 90% to100%), the minority genes from differ-
ent regions were excluded from the calculations.
Ridge regression and competitive selection
Unless otherwise stated, ridge regression was used with
the ridge parameter set by leave-one-out cross-validation
in the training set (values ranged from 25 to 120).
Competitive selection was carried out on the merged
dataset of 793 ER+ samples from the GSE6532, GSE1456,
GSE3494, GSE7390 and GSE2034 datasets. One hundred
random sample sets, each with 396 tumours, were drawn
from the pool. The ridge regression model was then built
up selecting the RMG at each step that best improved
the fit. The ridge parameter was fixed at a value of 25 for
this analysis. The average RMG rank and correlation of
the fit at each step was then recorded.
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repeated for each permutation in this analysis, and thus
w ea r eo n l yt e s t i n gt h ec o n s i s t e n c yo ft h er e g r e s s i o n
weightings given a fixed set of RMGs.
Interaction network analysis
Gene lists from the proliferation metagene and RMGs 1
to 7 (and subsequently RMGs 15, 17 and 26) were sub-
mitted to ROCK [31] for network generation http://
rock.icr.ac.uk. The resultant network was visualised with
ROCKscape (manuscript in preparation), a modification
of Cytoscape http://www.cytoscape.org that allows inte-
gration with ROCK-BCGF. Network metrics were
derived with the RandomNetworks plugin http://sites.
google.com/site/randomnetworkplugin/.
Additional material
Additional file 1: Genomic regions co-expressed in four out of five
datasets. This excel spreadsheet lists the Genomic regions co-expressed
in 4/5 datasets. Regions are given in megabases. Cluster refers to a
cluster of paralogs from the same gene family.
Additional file 2: Correlation of variable genes to proliferation.
Histograms of correlations of gene expression to the proliferation
metagene for the 5466 most variable genes from ER+ tumours in five
datasets. The cluster of genes that constitute the proliferation metagene
form a small peak or shoulder at high correlation.
Additional file 3: The microarray probes included in the
proliferation signature. This excel spreadsheet lists the microarray
probes from the Affymetrix U133A platform that were included in the
proliferation metagene in this study, along with their gene annotations.
Additional file 4: The microarray probes included in the 42 regional
metagenes. This excel spreadsheet lists the microarray probes from the
Affymetrix U133A platform that were included in the 42 regional
metagene in this study, along with their gene annotations.
Additional file 5: The interaction network defined by the
proliferation metagenes and the top seven regional metagenes.T h e
cytoscape file used to generate Figure 7A.
Additional file 6: Proliferation metagene targets hit by regional
metagenes. This Word document describes the proliferation metagene
genes targeted by (A) RMG 1 and RMG 26 (8q13-22 and 8q24) (B) RMG 2
and RMG 17 (8p12-22 and Xq22) (C) RMG 3 and RMG 15 (11q13 and
16q13-22) and (D) RMG 4 and RMG 17 (7p15 and Xq22). See Figure 7B
legend for details.
Additional file 7: Distance function for GDEC clustering. The GDEC
clustering method uses a local distortion of the correlation distance
between genes in the same chromosomal region. The three dimensional
plot illustrates the function used to relate genomic distance and
correlation to the output distance. The red line indicates the unadjusted
correlation distance at a genomic distance of zero.
Acknowledgements
The authors would like to thank Prof. Alan Ashworth of the Institute for
comments on the manuscript. We acknowledge funding from Breakthrough
Breast Cancer and NHS funding to the NIHR Biomedical Research Centre.
Authors’ contributions
TD conceived the study, programmed the algorithms and carried out the
statistical analyses. DS assisted in study design and DS drafted the
manuscript. CM performed the network analysis. AM and AG retrieved and
annotated gene expression datasets. AA edited mathematical equations
(Latex) for publication. All authors read and approved the final manuscript.
Received: 1 March 2010 Accepted: 8 September 2010
Published: 8 September 2010
References
1. Bergamaschi A, Kim YH, Wang P, Sorlie T, Hernandez-Boussard T,
Lonning PE, Tibshirani R, Borresen-Dale AL, Pollack JR: Distinct patterns of
DNA copy number alteration are associated with different
clinicopathological features and gene-expression subtypes of breast
cancer. Genes Chromosomes Cancer 2006, 45:1033-1040.
2. Hicks J, Krasnitz A, Lakshmi B, Navin NE, Riggs M, Leibu E, Esposito D,
Alexander J, Troge J, Grubor V, Yoon S, Wigler M, Ye K, Borresen-Dale AL,
Naume B, Schlicting E, Norton L, Hagerstrom T, Skoog L, Auer G, Maner S,
Lundin P, Zetterberg A: Novel patterns of genome rearrangement and
their association with survival in breast cancer. Genome Res 2006,
16:1465-1479.
3. Korsching E, Packeisen J, Helms MW, Kersting C, Voss R, van Diest PJ,
Brandt B, van der Wall E, Boecker W, Burger H: Deciphering a subgroup of
breast carcinomas with putative progression of grade during
carcinogenesis revealed by comparative genomic hybridisation (CGH)
and immunohistochemistry. Br J Cancer 2004, 90:1422-1428.
4. Simpson PT, Reis-Filho JS, Gale T, Lakhani SR: Molecular evolution of
breast cancer. J Pathol 2005, 205:248-254.
5. Pollack JR, Sorlie T, Perou CM, Rees CA, Jeffrey SS, Lonning PE, Tibshirani R,
Botstein D, Borresen-Dale AL, Brown PO: Microarray analysis reveals a
major direct role of DNA copy number alteration in the transcriptional
program of human breast tumors. Proc Natl Acad Sci USA 2002,
99:12963-12968.
6. Novak P, Jensen T, Oshiro MM, Watts GS, Kim CJ, Futscher BW:
Agglomerative epigenetic aberrations are a common event in human
breast cancer. Cancer Res 2008, 68:8616-8625.
7. Dai H, van’t Veer L, Lamb J, He YD, Mao M, Fine BM, Bernards R, van de
Vijver M, Deutsch P, Sachs A, Stoughton R, Friend S: A cell proliferation
signature is a marker of extremely poor outcome in a subpopulation of
breast cancer patients. Cancer Res 2005, 65:4059-4066.
8. Whitfield ML, Sherlock G, Saldanha AJ, Murray JI, Ball CA, Alexander KE,
Matese JC, Perou CM, Hurt MM, Brown PO, Botstein D: Identification of
genes periodically expressed in the human cell cycle and their
expression in tumors. Mol Biol Cell 2002, 13:1977-2000.
9. Whitfield ML, George LK, Grant GD, Perou CM: Common markers of
proliferation. Nat Rev Cancer 2006, 6:99-106.
10. Sotiriou C, Wirapati P, Loi S, Harris A, Fox S, Smeds J, Nordgren H, Farmer P,
Praz V, Haibe-Kains B, Desmedt C, Larsimont D, Cardoso F, Peterse H,
Nuyten D, Buyse M, Van de Vijver MJ, Bergh J, Piccart M, Delorenzi M: Gene
expression profiling in breast cancer: understanding the molecular basis
of histologic grade to improve prognosis. J Natl Cancer Inst 2006,
98:262-272.
11. Loi S, Haibe-Kains B, Desmedt C, Lallemand F, Tutt AM, Gillet C, Ellis P,
Harris A, Bergh J, Foekens JA, Klijn JG, Larsimont D, Buyse M, Bontempi G,
Delorenzi M, Piccart MJ, Sotiriou C: Definition of clinically distinct
molecular subtypes in estrogen receptor-positive breast carcinomas
through genomic grade. J Clin Oncol 2007, 25:1239-1246.
12. Ignatiadis M, Sotiriou C: Understanding the molecular basis of histologic
grade. Pathobiology 2008, 75:104-111.
13. Huang E, Ishida S, Pittman J, Dressman H, Bild A, Kloos M, D’Amico M,
Pestell RG, West M, Nevins JR: Gene expression phenotypic models that
predict the activity of oncogenic pathways. Nat Genet 2003, 34:226-230.
14. Brunet JP, Tamayo P, Golub TR, Mesirov JP: Metagenes and molecular
pattern discovery using matrix factorization. Proc Natl Acad Sci USA 2004,
101:4164-4169.
15. Everitt BS, Landau S, Leese M: Cluster Analysis London: Arnold, 4 2001.
16. Desmedt C, Piette F, Loi S, Wang Y, Lallemand F, Haibe-Kains B, Viale G,
Delorenzi M, Zhang Y, d’Assignies MS, Bergh J, Lidereau R, Ellis P, Harris AL,
Klijn JG, Foekens JA, Cardoso F, Piccart MJ, Buyse M, Sotiriou C: Strong time
dependence of the 76-gene prognostic signature for node-negative
breast cancer patients in the TRANSBIG multicenter independent
validation series. Clin Cancer Res 2007, 13:3207-3214.
Dexter et al. BMC Systems Biology 2010, 4:127
http://www.biomedcentral.com/1752-0509/4/127
Page 13 of 1417. Miller LD, Smeds J, George J, Vega VB, Vergara L, Ploner A, Pawitan Y,
Hall P, Klaar S, Liu ET, Bergh J: An expression signature for p53 status in
human breast cancer predicts mutation status, transcriptional effects,
and patient survival. Proc Natl Acad Sci USA 2005, 102:13550-13555.
18. Pawitan Y, Bjohle J, Amler L, Borg AL, Egyhazi S, Hall P, Han X, Holmberg L,
Huang F, Klaar S, Liu ET, Miller L, Nordgren H, Ploner A, Sandelin K,
Shaw PM, Smeds J, Skoog L, Wedren S, Bergh J: Gene expression profiling
spares early breast cancer patients from adjuvant therapy: derived and
validated in two population-based cohorts. Breast Cancer Res 2005, 7:
R953-964.
19. Wang Y, Klijn JG, Zhang Y, Sieuwerts AM, Look MP, Yang F, Talantov D,
Timmermans M, Meijer-van Gelder ME, Yu J, Jatkoe T, Berns EM, Atkins D,
Foekens JA: Gene-expression profiles to predict distant metastasis of
lymph-node-negative primary breast cancer. Lancet 2005, 365:671-679.
20. Chin K, DeVries S, Fridlyand J, Spellman PT, Roydasgupta R, Kuo WL,
Lapuk A, Neve RM, Qian Z, Ryder T, Chen F, Feiler H, Tokuyasu T, Kingsley C,
Dairkee S, Meng Z, Chew K, Pinkel D, Jain A, Ljung BM, Esserman L,
Albertson DG, Waldman FM, Gray JW: Genomic and transcriptional
aberrations linked to breast cancer pathophysiologies. Cancer Cell 2006,
10:529-541.
21. Witcher M, Emerson BM: Epigenetic silencing of the p16(INK4a) tumor
suppressor is associated with loss of CTCF binding and a chromatin
boundary. Mol Cell 2009, 34:271-284.
22. Novak P, Jensen T, Oshiro MM, Wozniak RJ, Nouzova M, Watts GS,
Klimecki WT, Kim C, Futscher BW: Epigenetic inactivation of the HOXA
gene cluster in breast cancer. Cancer Res 2006, 66:10664-10670.
23. Raman V, Martensen SA, Reisman D, Evron E, Odenwald WF, Jaffee E,
Marks J, Sukumar S: Compromised HOXA5 function can limit p53
expression in human breast tumours. Nature 2000, 405:974-978.
24. Chen H, Chung S, Sukumar S: HOXA5-induced apoptosis in breast cancer
cells is mediated by caspases 2 and 8. Mol Cell Biol 2004, 24:924-935.
25. Jansen MP, Sieuwerts AM, Look MP, Ritstier K, Meijer-van Gelder ME, van
Staveren IL, Klijn JG, Foekens JA, Berns EM: HOXB13-to-IL17BR expression
ratio is related with tumor aggressiveness and response to tamoxifen of
recurrent breast cancer: a retrospective study. J Clin Oncol 2007,
25:662-668.
26. Shivakumar L, Minna J, Sakamaki T, Pestell R, White MA: The RASSF1A
tumor suppressor blocks cell cycle progression and inhibits cyclin D1
accumulation. Mol Cell Biol 2002, 22:4309-4318.
27. Edgar R, Domrachev M, Lash AE: Gene Expression Omnibus: NCBI gene
expression and hybridization array data repository. Nucleic Acids Res 2002,
30:207-210.
28. Bolstad BM, Irizarry RA, Astrand M, Speed TP: A comparison of
normalization methods for high density oligonucleotide array data
based on variance and bias. Bioinformatics 2003, 19:185-193.
29. Olshen AB, Venkatraman ES, Lucito R, Wigler M: Circular binary
segmentation for the analysis of array-based DNA copy number data.
Biostatistics 2004, 5:557-572.
30. Lance GN, Williams WT: A general theory of classificatory sorting
strategies: 1. Hierarchical systems. Computer Journal 1967, 9:373-380.
31. Sims D, Bursteinas B, Gao Q, Jain E, Mackay A, Mitsopoulos C, Zvelebil M:
ROCK: a breast cancer functional genomics resource. Breast Cancer Res
Treat .
doi:10.1186/1752-0509-4-127
Cite this article as: Dexter et al.: Genomic distance entrained clustering
and regression modelling highlights interacting genomic regions
contributing to proliferation in breast cancer. BMC Systems Biology 2010
4:127. Submit your next manuscript to BioMed Central
and take full advantage of: 
• Convenient online submission
• Thorough peer review
• No space constraints or color ﬁgure charges
• Immediate publication on acceptance
• Inclusion in PubMed, CAS, Scopus and Google Scholar
• Research which is freely available for redistribution
Submit your manuscript at 
www.biomedcentral.com/submit
Dexter et al. BMC Systems Biology 2010, 4:127
http://www.biomedcentral.com/1752-0509/4/127
Page 14 of 14